Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Schedule of Segment Profitability That Are Most Relied Upon By the Codm Are Gross Revenues and Net Loss

The measures of segment profitability that are most relied upon by the CODM are gross revenues and net loss, as presented within the table below and reconciled to the statement of operations.

	Three Months Ended June 30, 2023
	Dominari Securities			Legacy AIkido Pharma			Consolidated
Revenue	$	71		$	-		$	71
Operating Costs
General and administrative		6,957			2,123		$	9,080
Research and development					2			2
Loss from operations	$	(6,886	)	$	(2,125	)	$	(9,011	)
Other (expenses) income
Other income								-
Interest income		44			116			160
Loss on marketable securities					400			400
Unrealized loss on note receivable					(212	)		(212	)
Total other (expenses) income	$	44		$	304		$	348
Net loss	$	(6,842	)	$	(1,821	)	$	(8,663	)

	Six Months Ended June 30, 2023
	Dominari Securities			Legacy AIkido Pharma			Consolidated
Revenue	$	71		$	-		$	71
Operating Costs
General and administrative		8,056			4,857			12,913
Research and development					3			3
Loss from operations	$	(7,985	)	$	(4,860	)	$	(12,845	)
Other (expenses) income
Other income					-			-
Interest income		44			253			297
Loss on marketable securities					335			335
Unrealized loss on note receivable					(212	)		(212	)
Total other (expenses) income	$	44		$	376		$	420
Net loss	$	(7,941	)	$	(4,484	)	$	(12,425	)